

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.74810553 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.74810553 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.11770213 |
| 4 | axon ensheathment (GO:0008366) | 3.76844272 |
| 5 | ensheathment of neurons (GO:0007272) | 3.76844272 |
| 6 | myelination (GO:0042552) | 3.75401362 |
| 7 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.72352955 |
| 8 | sodium ion export (GO:0071436) | 3.69773630 |
| 9 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.54817301 |
| 10 | fatty acid elongation (GO:0030497) | 3.52876855 |
| 11 | negative regulation of neurotransmitter transport (GO:0051589) | 3.51648436 |
| 12 | neuronal action potential propagation (GO:0019227) | 3.42055390 |
| 13 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.41945901 |
| 14 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.40436840 |
| 15 | cellular sodium ion homeostasis (GO:0006883) | 3.17713195 |
| 16 | negative regulation of protein localization to cell surface (GO:2000009) | 3.16523256 |
| 17 | myelin maintenance (GO:0043217) | 3.01632038 |
| 18 | desmosome organization (GO:0002934) | 2.99369268 |
| 19 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.98539960 |
| 20 | cell communication by electrical coupling (GO:0010644) | 2.96558256 |
| 21 | positive regulation of muscle hypertrophy (GO:0014742) | 2.87886625 |
| 22 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.87886625 |
| 23 | eye photoreceptor cell differentiation (GO:0001754) | 2.87163894 |
| 24 | photoreceptor cell differentiation (GO:0046530) | 2.87163894 |
| 25 | neuron remodeling (GO:0016322) | 2.79794070 |
| 26 | synaptic vesicle maturation (GO:0016188) | 2.79428700 |
| 27 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.78689557 |
| 28 | apical protein localization (GO:0045176) | 2.72498915 |
| 29 | presynaptic membrane organization (GO:0097090) | 2.69717601 |
| 30 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.67735632 |
| 31 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.67158230 |
| 32 | cellular potassium ion homeostasis (GO:0030007) | 2.66527754 |
| 33 | cerebellar granule cell differentiation (GO:0021707) | 2.66266458 |
| 34 | protein localization to endosome (GO:0036010) | 2.66115518 |
| 35 | L-amino acid import (GO:0043092) | 2.65918023 |
| 36 | presynaptic membrane assembly (GO:0097105) | 2.65199073 |
| 37 | asymmetric protein localization (GO:0008105) | 2.62932556 |
| 38 | neuron cell-cell adhesion (GO:0007158) | 2.60829561 |
| 39 | negative regulation of complement activation (GO:0045916) | 2.60136567 |
| 40 | nerve growth factor signaling pathway (GO:0038180) | 2.59596892 |
| 41 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.59040095 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.58675288 |
| 43 | cell communication involved in cardiac conduction (GO:0086065) | 2.58586989 |
| 44 | positive regulation of potassium ion transport (GO:0043268) | 2.57994349 |
| 45 | transmission of nerve impulse (GO:0019226) | 2.57406017 |
| 46 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.56170364 |
| 47 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.55712577 |
| 48 | synaptic vesicle exocytosis (GO:0016079) | 2.55242105 |
| 49 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.54574793 |
| 50 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.53763918 |
| 51 | negative regulation of protein activation cascade (GO:2000258) | 2.50887891 |
| 52 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.48322489 |
| 53 | potassium ion import (GO:0010107) | 2.47312332 |
| 54 | creatine metabolic process (GO:0006600) | 2.46595253 |
| 55 | macroautophagy (GO:0016236) | 2.46207856 |
| 56 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.45304909 |
| 57 | mating behavior (GO:0007617) | 2.44646812 |
| 58 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.44582082 |
| 59 | membrane assembly (GO:0071709) | 2.42485058 |
| 60 | glycine transport (GO:0015816) | 2.42299999 |
| 61 | response to methylmercury (GO:0051597) | 2.42162157 |
| 62 | regulation of cell communication by electrical coupling (GO:0010649) | 2.41921673 |
| 63 | oligodendrocyte differentiation (GO:0048709) | 2.41279650 |
| 64 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.39731911 |
| 65 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.39541081 |
| 66 | relaxation of cardiac muscle (GO:0055119) | 2.38586100 |
| 67 | relaxation of muscle (GO:0090075) | 2.38245777 |
| 68 | establishment of mitochondrion localization (GO:0051654) | 2.37899398 |
| 69 | glutamate secretion (GO:0014047) | 2.37710132 |
| 70 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.36689324 |
| 71 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.36621202 |
| 72 | Golgi to plasma membrane protein transport (GO:0043001) | 2.35010122 |
| 73 | neuron recognition (GO:0008038) | 2.34669923 |
| 74 | inositol phosphate-mediated signaling (GO:0048016) | 2.33612530 |
| 75 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.32672799 |
| 76 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.31784485 |
| 77 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.31088049 |
| 78 | adult walking behavior (GO:0007628) | 2.31072604 |
| 79 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.29548528 |
| 80 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.29548528 |
| 81 | adhesion of symbiont to host cell (GO:0044650) | 2.28849814 |
| 82 | virion attachment to host cell (GO:0019062) | 2.28849814 |
| 83 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.27074287 |
| 84 | detection of calcium ion (GO:0005513) | 2.26493287 |
| 85 | import into cell (GO:0098657) | 2.26476179 |
| 86 | peripheral nervous system axon ensheathment (GO:0032292) | 2.26212150 |
| 87 | myelination in peripheral nervous system (GO:0022011) | 2.26212150 |
| 88 | magnesium ion transport (GO:0015693) | 2.24930787 |
| 89 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.24749692 |
| 90 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.23919962 |
| 91 | vesicle transport along microtubule (GO:0047496) | 2.23395614 |
| 92 | glutamate receptor signaling pathway (GO:0007215) | 2.22821411 |
| 93 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.20383442 |
| 94 | response to redox state (GO:0051775) | 2.20135480 |
| 95 | regulation of vesicle fusion (GO:0031338) | 2.19936912 |
| 96 | response to epinephrine (GO:0071871) | 2.19917773 |
| 97 | regulation of collateral sprouting (GO:0048670) | 2.19781472 |
| 98 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.19628368 |
| 99 | lung lobe morphogenesis (GO:0060463) | 2.19413275 |
| 100 | potassium ion homeostasis (GO:0055075) | 2.18901636 |
| 101 | tonic smooth muscle contraction (GO:0014820) | 2.17026150 |
| 102 | cellular response to epinephrine stimulus (GO:0071872) | 2.16354659 |
| 103 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.16136691 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 2.16107954 |
| 105 | negative regulation of synaptic transmission (GO:0050805) | 2.16058550 |
| 106 | positive regulation of fibroblast migration (GO:0010763) | 2.16018896 |
| 107 | endocrine hormone secretion (GO:0060986) | 2.15634828 |
| 108 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.15480994 |
| 109 | dendrite morphogenesis (GO:0048813) | 2.14764586 |
| 110 | neuronal ion channel clustering (GO:0045161) | 2.14629789 |
| 111 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.14560676 |
| 112 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.14511175 |
| 113 | negative regulation of JUN kinase activity (GO:0043508) | 2.14155038 |
| 114 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.14021656 |
| 115 | axonal fasciculation (GO:0007413) | 2.13475630 |
| 116 | substantia nigra development (GO:0021762) | 2.13465200 |
| 117 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.13102594 |
| 118 | relaxation of smooth muscle (GO:0044557) | 2.12997894 |
| 119 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.12908293 |
| 120 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.12906471 |
| 121 | regulation of muscle hypertrophy (GO:0014743) | 2.12855497 |
| 122 | neuron-neuron synaptic transmission (GO:0007270) | 2.12187011 |
| 123 | regulation of muscle adaptation (GO:0043502) | 2.11958359 |
| 124 | organelle transport along microtubule (GO:0072384) | 2.11592685 |
| 125 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.11512499 |
| 126 | smooth muscle tissue development (GO:0048745) | 2.11146630 |
| 127 | regulation of synaptic vesicle transport (GO:1902803) | 2.11066779 |
| 128 | regulation of complement activation (GO:0030449) | 2.10938389 |
| 129 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.10766144 |
| 130 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.10594994 |
| 131 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.09909396 |
| 132 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.09909396 |
| 133 | cellular response to monoamine stimulus (GO:0071868) | 2.09622929 |
| 134 | cellular response to catecholamine stimulus (GO:0071870) | 2.09622929 |
| 135 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.09536432 |
| 136 | response to gravity (GO:0009629) | 2.08998099 |
| 137 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.08893640 |
| 138 | negative regulation of axonogenesis (GO:0050771) | 2.08699806 |
| 139 | astrocyte development (GO:0014002) | 2.08687917 |
| 140 | neuronal action potential (GO:0019228) | 2.08180575 |
| 141 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.08037709 |
| 142 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.07525529 |
| 143 | Golgi to endosome transport (GO:0006895) | 2.07290555 |
| 144 | cell adhesion mediated by integrin (GO:0033627) | 2.07017201 |
| 145 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.06953957 |
| 146 | neurotransmitter secretion (GO:0007269) | 2.06951435 |
| 147 | locomotory exploration behavior (GO:0035641) | 2.06915678 |
| 148 | clathrin coat assembly (GO:0048268) | 2.06401854 |
| 149 | protein localization to synapse (GO:0035418) | 2.06346060 |
| 150 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.06006834 |
| 151 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.05582309 |
| 152 | regulation of energy homeostasis (GO:2000505) | 2.05158808 |
| 153 | regulation of protein activation cascade (GO:2000257) | 2.04857614 |
| 154 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.04187215 |
| 155 | COPII vesicle coating (GO:0048208) | 2.03844344 |
| 156 | regulation of lipoprotein metabolic process (GO:0050746) | 2.03582177 |
| 157 | skin morphogenesis (GO:0043589) | 2.01670058 |
| 158 | cardiac conduction (GO:0061337) | 2.00441287 |
| 159 | positive regulation of extracellular matrix organization (GO:1903055) | 1.96574170 |
| 160 | regulation of cardiac muscle cell contraction (GO:0086004) | 1.95477164 |
| 161 | sodium ion homeostasis (GO:0055078) | 1.95031470 |
| 162 | regulation of Rac protein signal transduction (GO:0035020) | 1.94643201 |
| 163 | endothelium development (GO:0003158) | 1.94548098 |
| 164 | positive regulation of glycolytic process (GO:0045821) | 1.92801040 |
| 165 | glomerular basement membrane development (GO:0032836) | 1.92203911 |
| 166 | cerebellar Purkinje cell differentiation (GO:0021702) | 1.91565451 |
| 167 | regulation of actin filament-based movement (GO:1903115) | 1.90484522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.08759724 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.92307843 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.60475767 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.51701572 |
| 5 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25735018 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.25676979 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.20263395 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.19966401 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.19966401 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.14155335 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.07694009 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.04172495 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.02767299 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02179472 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.00069626 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.94131130 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.93777901 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.87344787 |
| 19 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.85291693 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.84336391 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79166403 |
| 22 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.73695472 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.71905258 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.71063267 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70492801 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.68050505 |
| 27 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67211061 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64571310 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.64383291 |
| 30 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.62471307 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.59468927 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58581682 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.54990018 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54716970 |
| 35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.53466556 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52619847 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.51350476 |
| 38 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.51350476 |
| 39 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.49488953 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45547610 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42585917 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40959554 |
| 43 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40708544 |
| 44 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39768578 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38230524 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38147276 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37869994 |
| 48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.37164635 |
| 49 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36578808 |
| 50 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36318293 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36009395 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33779945 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33366480 |
| 54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.33331381 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32930334 |
| 56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32272927 |
| 57 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.31763781 |
| 58 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.31382878 |
| 59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.31185896 |
| 60 | TP53_16413492_ChIP-PET_HCT116_Human | 1.30490960 |
| 61 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29323269 |
| 62 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28790669 |
| 63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28600620 |
| 64 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28479884 |
| 65 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28247143 |
| 66 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27177775 |
| 67 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24763461 |
| 68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23269800 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22921720 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21534733 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20192274 |
| 72 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.20091159 |
| 73 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.18651061 |
| 74 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18010465 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17858704 |
| 76 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.17847316 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.17737644 |
| 78 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.17138750 |
| 79 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16582071 |
| 80 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15676993 |
| 81 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15225416 |
| 82 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14277250 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12108996 |
| 84 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.11564474 |
| 85 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11525937 |
| 86 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11451480 |
| 87 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11451480 |
| 88 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09011856 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08945543 |
| 90 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08659326 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07943738 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07918773 |
| 93 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07835964 |
| 94 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07683371 |
| 95 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06029531 |
| 96 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05455663 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05261225 |
| 98 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04818476 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04699866 |
| 100 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04523062 |
| 101 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.03557333 |
| 102 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.03117452 |
| 103 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01525479 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99055976 |
| 105 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.98778175 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98479626 |
| 107 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98188901 |
| 108 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98055834 |
| 109 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98054484 |
| 110 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97887804 |
| 111 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97452928 |
| 112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96861054 |
| 113 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96830345 |
| 114 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96789280 |
| 115 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95951743 |
| 116 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95951743 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95048533 |
| 118 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.94855132 |
| 119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94529955 |
| 120 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94511074 |
| 121 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.93218864 |
| 122 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92721836 |
| 123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92211757 |
| 124 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90933897 |
| 125 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89973526 |
| 126 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.89654899 |
| 127 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89283115 |
| 128 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89097013 |
| 129 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89014493 |
| 130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88542585 |
| 131 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87970698 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87608345 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86908843 |
| 134 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.86653456 |
| 135 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85736866 |
| 136 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.85617797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004270_analgesia | 3.60739741 |
| 2 | MP0003880_abnormal_central_pattern | 3.58964000 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.30352191 |
| 4 | MP0000920_abnormal_myelination | 3.17379347 |
| 5 | MP0010368_abnormal_lymphatic_system | 2.65754589 |
| 6 | MP0002272_abnormal_nervous_system | 2.38131108 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 2.34319071 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.32319390 |
| 9 | MP0002064_seizures | 2.20124954 |
| 10 | MP0003329_amyloid_beta_deposits | 2.19860852 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.14599763 |
| 12 | MP0005171_absent_coat_pigmentation | 2.13944561 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.10597694 |
| 14 | MP0009745_abnormal_behavioral_response | 2.09527622 |
| 15 | MP0009046_muscle_twitch | 2.00136266 |
| 16 | MP0003690_abnormal_glial_cell | 1.98708169 |
| 17 | MP0001486_abnormal_startle_reflex | 1.94882706 |
| 18 | MP0002735_abnormal_chemical_nociception | 1.94662739 |
| 19 | MP0000013_abnormal_adipose_tissue | 1.80437190 |
| 20 | MP0003868_abnormal_feces_composition | 1.80341489 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 1.75993941 |
| 22 | MP0002063_abnormal_learning/memory/cond | 1.75582645 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 1.74884879 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.73468652 |
| 25 | MP0002736_abnormal_nociception_after | 1.73284363 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.70359858 |
| 27 | MP0006138_congestive_heart_failure | 1.68788114 |
| 28 | MP0004885_abnormal_endolymph | 1.68003348 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.66556828 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.62991774 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.62758752 |
| 32 | MP0001970_abnormal_pain_threshold | 1.62671436 |
| 33 | MP0003879_abnormal_hair_cell | 1.60091552 |
| 34 | MP0003634_abnormal_glial_cell | 1.59427850 |
| 35 | MP0002733_abnormal_thermal_nociception | 1.55895620 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.54634073 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.53401039 |
| 38 | MP0003279_aneurysm | 1.52695636 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.50895109 |
| 40 | MP0001299_abnormal_eye_distance/ | 1.50087524 |
| 41 | MP0000751_myopathy | 1.49782794 |
| 42 | MP0001905_abnormal_dopamine_level | 1.48550278 |
| 43 | MP0002822_catalepsy | 1.45908089 |
| 44 | MP0005670_abnormal_white_adipose | 1.42885755 |
| 45 | MP0004272_abnormal_basement_membrane | 1.41989657 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.40723079 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.40385460 |
| 48 | MP0004742_abnormal_vestibular_system | 1.39864173 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.39243263 |
| 50 | MP0005409_darkened_coat_color | 1.39105780 |
| 51 | MP0003633_abnormal_nervous_system | 1.38875724 |
| 52 | MP0000778_abnormal_nervous_system | 1.37997399 |
| 53 | MP0008569_lethality_at_weaning | 1.37950482 |
| 54 | MP0005423_abnormal_somatic_nervous | 1.30608007 |
| 55 | MP0000749_muscle_degeneration | 1.27726928 |
| 56 | MP0001529_abnormal_vocalization | 1.26552349 |
| 57 | MP0002229_neurodegeneration | 1.23856276 |
| 58 | MP0004142_abnormal_muscle_tone | 1.23593713 |
| 59 | MP0000747_muscle_weakness | 1.22501450 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.22151179 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.21638146 |
| 62 | MP0000566_synostosis | 1.21443985 |
| 63 | MP0004858_abnormal_nervous_system | 1.20110370 |
| 64 | MP0003631_nervous_system_phenotype | 1.18943264 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.18257504 |
| 66 | MP0004924_abnormal_behavior | 1.16038880 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.16038880 |
| 68 | MP0002896_abnormal_bone_mineralization | 1.14643655 |
| 69 | MP0010678_abnormal_skin_adnexa | 1.14508431 |
| 70 | MP0004043_abnormal_pH_regulation | 1.12270577 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.11703366 |
| 72 | MP0006276_abnormal_autonomic_nervous | 1.11631647 |
| 73 | MP0000955_abnormal_spinal_cord | 1.11545590 |
| 74 | MP0000003_abnormal_adipose_tissue | 1.10398385 |
| 75 | MP0002882_abnormal_neuron_morphology | 1.10358603 |
| 76 | MP0003828_pulmonary_edema | 1.09185900 |
| 77 | MP0005646_abnormal_pituitary_gland | 1.08910871 |
| 78 | MP0002184_abnormal_innervation | 1.08265735 |
| 79 | MP0003091_abnormal_cell_migration | 1.08158746 |
| 80 | MP0008775_abnormal_heart_ventricle | 1.07636112 |
| 81 | MP0005275_abnormal_skin_tensile | 1.07555058 |
| 82 | MP0000569_abnormal_digit_pigmentation | 1.07152984 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 1.06718285 |
| 84 | MP0003045_fibrosis | 1.06181419 |
| 85 | MP0000604_amyloidosis | 1.06039105 |
| 86 | MP0004484_altered_response_of | 1.05397539 |
| 87 | MP0002295_abnormal_pulmonary_circulatio | 1.04915384 |
| 88 | MP0005023_abnormal_wound_healing | 1.03988705 |
| 89 | MP0002909_abnormal_adrenal_gland | 1.02941300 |
| 90 | MP0002971_abnormal_brown_adipose | 1.02775577 |
| 91 | MP0002066_abnormal_motor_capabilities/c | 1.02678001 |
| 92 | MP0008004_abnormal_stomach_pH | 1.02571697 |
| 93 | MP0005165_increased_susceptibility_to | 1.02241923 |
| 94 | MP0003632_abnormal_nervous_system | 1.01465981 |
| 95 | MP0004215_abnormal_myocardial_fiber | 0.97834237 |
| 96 | MP0005620_abnormal_muscle_contractility | 0.97772438 |
| 97 | * MP0004036_abnormal_muscle_relaxation | 0.97005178 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.96672386 |
| 99 | MP0002090_abnormal_vision | 0.95817862 |
| 100 | MP0004085_abnormal_heartbeat | 0.93901624 |
| 101 | * MP0004087_abnormal_muscle_fiber | 0.93441025 |
| 102 | MP0004134_abnormal_chest_morphology | 0.91372602 |
| 103 | MP0005375_adipose_tissue_phenotype | 0.89938040 |
| 104 | MP0001502_abnormal_circadian_rhythm | 0.89190594 |
| 105 | MP0003136_yellow_coat_color | 0.88630530 |
| 106 | MP0003195_calcinosis | 0.88603582 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.88061914 |
| 108 | MP0001177_atelectasis | 0.87901172 |
| 109 | MP0002108_abnormal_muscle_morphology | 0.87250263 |
| 110 | MP0005365_abnormal_bile_salt | 0.86626113 |
| 111 | MP0004147_increased_porphyrin_level | 0.85156437 |
| 112 | MP0002972_abnormal_cardiac_muscle | 0.83844343 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.83798863 |
| 114 | MP0002269_muscular_atrophy | 0.83338905 |
| 115 | MP0001984_abnormal_olfaction | 0.83336250 |
| 116 | MP0005503_abnormal_tendon_morphology | 0.83273920 |
| 117 | MP0010386_abnormal_urinary_bladder | 0.81755233 |
| 118 | MP0010329_abnormal_lipoprotein_level | 0.81572948 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.81305063 |
| 120 | MP0000639_abnormal_adrenal_gland | 0.80951049 |
| 121 | MP0001666_abnormal_nutrient_absorption | 0.80711421 |
| 122 | MP0002168_other_aberrant_phenotype | 0.80697353 |
| 123 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80346994 |
| 124 | MP0003137_abnormal_impulse_conducting | 0.80083146 |
| 125 | MP0001346_abnormal_lacrimal_gland | 0.80023988 |
| 126 | MP0002557_abnormal_social/conspecific_i | 0.79289266 |
| 127 | MP0003075_altered_response_to | 0.79108243 |
| 128 | MP0001958_emphysema | 0.78760669 |
| 129 | MP0004811_abnormal_neuron_physiology | 0.78719045 |
| 130 | MP0005385_cardiovascular_system_phenoty | 0.78234216 |
| 131 | MP0001544_abnormal_cardiovascular_syste | 0.78234216 |
| 132 | MP0004130_abnormal_muscle_cell | 0.77118633 |
| 133 | MP0000372_irregular_coat_pigmentation | 0.76713305 |
| 134 | MP0000383_abnormal_hair_follicle | 0.74934876 |
| 135 | MP0005330_cardiomyopathy | 0.74625635 |
| 136 | MP0004084_abnormal_cardiac_muscle | 0.74308840 |
| 137 | MP0001963_abnormal_hearing_physiology | 0.72300732 |
| 138 | MP0002752_abnormal_somatic_nervous | 0.72047599 |
| 139 | MP0005595_abnormal_vascular_smooth | 0.71862321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 4.78823349 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.16895039 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.16895039 |
| 4 | Focal motor seizures (HP:0011153) | 3.77155254 |
| 5 | Cerebral inclusion bodies (HP:0100314) | 3.74304610 |
| 6 | Myokymia (HP:0002411) | 3.64376076 |
| 7 | Insidious onset (HP:0003587) | 3.52204172 |
| 8 | Termporal pattern (HP:0011008) | 3.52204172 |
| 9 | Supranuclear gaze palsy (HP:0000605) | 3.51097592 |
| 10 | Aortic aneurysm (HP:0004942) | 3.45701839 |
| 11 | Febrile seizures (HP:0002373) | 3.33955690 |
| 12 | Aortic dissection (HP:0002647) | 3.27658530 |
| 13 | Protrusio acetabuli (HP:0003179) | 3.25086504 |
| 14 | Onion bulb formation (HP:0003383) | 3.23975591 |
| 15 | Action tremor (HP:0002345) | 3.23212744 |
| 16 | Abnormality of the corticospinal tract (HP:0002492) | 3.10997837 |
| 17 | Bundle branch block (HP:0011710) | 3.09724096 |
| 18 | Mitral stenosis (HP:0001718) | 2.98237038 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 2.97615245 |
| 20 | Pheochromocytoma (HP:0002666) | 2.97399644 |
| 21 | Sensory axonal neuropathy (HP:0003390) | 2.93381443 |
| 22 | Peripheral hypomyelination (HP:0007182) | 2.93015942 |
| 23 | Focal seizures (HP:0007359) | 2.92622270 |
| 24 | Dysmetria (HP:0001310) | 2.90892539 |
| 25 | Atonic seizures (HP:0010819) | 2.89009454 |
| 26 | Retinal dysplasia (HP:0007973) | 2.81521219 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 2.78892249 |
| 28 | Scanning speech (HP:0002168) | 2.75039526 |
| 29 | Ankle clonus (HP:0011448) | 2.73560069 |
| 30 | Intention tremor (HP:0002080) | 2.65440445 |
| 31 | Cerebral aneurysm (HP:0004944) | 2.63258073 |
| 32 | Aplasia involving bones of the extremities (HP:0009825) | 2.62692405 |
| 33 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.62692405 |
| 34 | Aplasia of the phalanges of the hand (HP:0009802) | 2.62692405 |
| 35 | Muscle fiber splitting (HP:0003555) | 2.60236614 |
| 36 | Neuroendocrine neoplasm (HP:0100634) | 2.53998447 |
| 37 | Ulnar claw (HP:0001178) | 2.53201515 |
| 38 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.50424698 |
| 39 | Type 1 muscle fiber predominance (HP:0003803) | 2.49370542 |
| 40 | Parakeratosis (HP:0001036) | 2.49028294 |
| 41 | Thickened helices (HP:0000391) | 2.46706209 |
| 42 | Striae distensae (HP:0001065) | 2.43881523 |
| 43 | Foot dorsiflexor weakness (HP:0009027) | 2.41012277 |
| 44 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.40424532 |
| 45 | Diplopia (HP:0000651) | 2.39684218 |
| 46 | Abnormality of binocular vision (HP:0011514) | 2.39684218 |
| 47 | Nemaline bodies (HP:0003798) | 2.39376554 |
| 48 | Osteolytic defects of the hand bones (HP:0009699) | 2.35862364 |
| 49 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.35862364 |
| 50 | Spastic gait (HP:0002064) | 2.34690782 |
| 51 | Cerebral hemorrhage (HP:0001342) | 2.33569198 |
| 52 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.33404229 |
| 53 | Muscle fiber inclusion bodies (HP:0100299) | 2.33075976 |
| 54 | Epileptic encephalopathy (HP:0200134) | 2.30139246 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.29747335 |
| 56 | Abnormal atrioventricular conduction (HP:0005150) | 2.26050739 |
| 57 | Hammertoe (HP:0001765) | 2.20750064 |
| 58 | Hypoplasia of the iris (HP:0007676) | 2.20484519 |
| 59 | Dialeptic seizures (HP:0011146) | 2.18727877 |
| 60 | Complement deficiency (HP:0004431) | 2.17488651 |
| 61 | Wormian bones (HP:0002645) | 2.16889875 |
| 62 | Heart block (HP:0012722) | 2.16675529 |
| 63 | Steppage gait (HP:0003376) | 2.16170905 |
| 64 | Abnormality of the foot musculature (HP:0001436) | 2.14213178 |
| 65 | Overgrowth (HP:0001548) | 2.12226829 |
| 66 | Autoamputation (HP:0001218) | 2.11335320 |
| 67 | Exercise-induced myalgia (HP:0003738) | 2.11287504 |
| 68 | Lower limb muscle weakness (HP:0007340) | 2.10912820 |
| 69 | Premature rupture of membranes (HP:0001788) | 2.10792046 |
| 70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10387277 |
| 71 | Progressive cerebellar ataxia (HP:0002073) | 2.08768545 |
| 72 | Alacrima (HP:0000522) | 2.08577816 |
| 73 | Buphthalmos (HP:0000557) | 2.08478226 |
| 74 | Axonal loss (HP:0003447) | 2.07190294 |
| 75 | Absence seizures (HP:0002121) | 2.07014120 |
| 76 | Difficulty running (HP:0009046) | 2.06121605 |
| 77 | Papillary thyroid carcinoma (HP:0002895) | 2.05492125 |
| 78 | Infantile muscular hypotonia (HP:0008947) | 2.03576529 |
| 79 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03029061 |
| 80 | Atrioventricular block (HP:0001678) | 2.02443944 |
| 81 | Dysdiadochokinesis (HP:0002075) | 2.01598541 |
| 82 | Calf muscle hypertrophy (HP:0008981) | 2.00722831 |
| 83 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.00110849 |
| 84 | Vascular calcification (HP:0004934) | 1.99712088 |
| 85 | Truncal ataxia (HP:0002078) | 1.99549357 |
| 86 | Megalencephaly (HP:0001355) | 1.99110223 |
| 87 | Clumsiness (HP:0002312) | 1.98262936 |
| 88 | Anxiety (HP:0000739) | 1.96407480 |
| 89 | Increased circulating renin level (HP:0000848) | 1.95187402 |
| 90 | Generalized tonic-clonic seizures (HP:0002069) | 1.94656886 |
| 91 | Gowers sign (HP:0003391) | 1.94048191 |
| 92 | Atrial fibrillation (HP:0005110) | 1.93690127 |
| 93 | Rapidly progressive (HP:0003678) | 1.93412899 |
| 94 | Tetraparesis (HP:0002273) | 1.92651020 |
| 95 | Broad metatarsal (HP:0001783) | 1.92511404 |
| 96 | Abnormal auditory evoked potentials (HP:0006958) | 1.91809531 |
| 97 | Obstructive sleep apnea (HP:0002870) | 1.91718773 |
| 98 | Dysmetric saccades (HP:0000641) | 1.91211170 |
| 99 | Papilledema (HP:0001085) | 1.90034747 |
| 100 | Aneurysm (HP:0002617) | 1.87066232 |
| 101 | Abnormality of the calf musculature (HP:0001430) | 1.87009806 |
| 102 | Visual hallucinations (HP:0002367) | 1.86916214 |
| 103 | Slow saccadic eye movements (HP:0000514) | 1.86044121 |
| 104 | EMG: myopathic abnormalities (HP:0003458) | 1.85357300 |
| 105 | Prolonged QT interval (HP:0001657) | 1.85336081 |
| 106 | Blue irides (HP:0000635) | 1.85328631 |
| 107 | Macroorchidism (HP:0000053) | 1.85178296 |
| 108 | Decreased motor nerve conduction velocity (HP:0003431) | 1.84402337 |
| 109 | Ventricular fibrillation (HP:0001663) | 1.84152460 |
| 110 | Broad-based gait (HP:0002136) | 1.83844840 |
| 111 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.83708470 |
| 112 | Anteriorly placed anus (HP:0001545) | 1.83624742 |
| 113 | Type II lissencephaly (HP:0007260) | 1.83013073 |
| 114 | Ventricular arrhythmia (HP:0004308) | 1.82748902 |
| 115 | Stridor (HP:0010307) | 1.80992592 |
| 116 | Hemiparesis (HP:0001269) | 1.80025958 |
| 117 | Subaortic stenosis (HP:0001682) | 1.78066018 |
| 118 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.78066018 |
| 119 | Neck muscle weakness (HP:0000467) | 1.77333701 |
| 120 | Bradycardia (HP:0001662) | 1.76306800 |
| 121 | Sudden death (HP:0001699) | 1.75738824 |
| 122 | Menstrual irregularities (HP:0000858) | 1.74252497 |
| 123 | Scapular winging (HP:0003691) | 1.74239849 |
| 124 | Gaze-evoked nystagmus (HP:0000640) | 1.73676054 |
| 125 | Akinesia (HP:0002304) | 1.72572312 |
| 126 | Primary atrial arrhythmia (HP:0001692) | 1.72482174 |
| 127 | Acanthosis nigricans (HP:0000956) | 1.70448094 |
| 128 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.69931150 |
| 129 | Round ear (HP:0100830) | 1.68743104 |
| 130 | Synostosis involving the elbow (HP:0003938) | 1.68325218 |
| 131 | Humeroradial synostosis (HP:0003041) | 1.68325218 |
| 132 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.67289629 |
| 133 | White forelock (HP:0002211) | 1.67067015 |
| 134 | Syncope (HP:0001279) | 1.66708795 |
| 135 | Hyperkalemia (HP:0002153) | 1.65831683 |
| 136 | Postural tremor (HP:0002174) | 1.65676354 |
| 137 | Postural instability (HP:0002172) | 1.65593071 |
| 138 | Distal sensory impairment (HP:0002936) | 1.65149629 |
| 139 | Urinary urgency (HP:0000012) | 1.65137683 |
| 140 | Increased connective tissue (HP:0009025) | 1.65035910 |
| 141 | Spondylolisthesis (HP:0003302) | 1.64911269 |
| 142 | Abnormality of complement system (HP:0005339) | 1.64794597 |
| 143 | Metabolic alkalosis (HP:0200114) | 1.64148148 |
| 144 | Arterial tortuosity (HP:0005116) | 1.63896292 |
| 145 | Submucous cleft hard palate (HP:0000176) | 1.63828931 |
| 146 | Limited hip movement (HP:0008800) | 1.63793090 |
| 147 | Vascular tortuosity (HP:0004948) | 1.63303681 |
| 148 | Testicular neoplasm (HP:0010788) | 1.63244954 |
| 149 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.62824870 |
| 150 | Hyperventilation (HP:0002883) | 1.62622573 |
| 151 | Cervical subluxation (HP:0003308) | 1.62478368 |
| 152 | Myotonia (HP:0002486) | 1.61199780 |
| 153 | Metaphyseal dysplasia (HP:0100255) | 1.61099852 |
| 154 | Spinal rigidity (HP:0003306) | 1.60521809 |
| 155 | Atrophic scars (HP:0001075) | 1.60303773 |
| 156 | Coronal craniosynostosis (HP:0004440) | 1.59936789 |
| 157 | Hypoalphalipoproteinemia (HP:0003233) | 1.59932063 |
| 158 | Torticollis (HP:0000473) | 1.59400386 |
| 159 | Abnormality of the intrinsic pathway (HP:0010989) | 1.58393208 |
| 160 | Supraventricular arrhythmia (HP:0005115) | 1.57440878 |
| 161 | Shallow orbits (HP:0000586) | 1.56831631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.48502928 |
| 2 | OXSR1 | 3.05604839 |
| 3 | EPHA4 | 2.49893520 |
| 4 | NTRK1 | 2.49495277 |
| 5 | EPHB1 | 2.36224568 |
| 6 | WNK4 | 2.35600843 |
| 7 | RIPK1 | 2.35321838 |
| 8 | AKT3 | 2.28289249 |
| 9 | NTRK3 | 2.21498754 |
| 10 | MAPKAPK5 | 2.03177432 |
| 11 | WNK1 | 1.99312240 |
| 12 | LATS2 | 1.90740962 |
| 13 | BCR | 1.77276666 |
| 14 | MST1R | 1.71624014 |
| 15 | RIPK4 | 1.71360441 |
| 16 | FGFR2 | 1.62777165 |
| 17 | MET | 1.59246356 |
| 18 | KSR2 | 1.58333205 |
| 19 | MAP3K2 | 1.55985873 |
| 20 | MAP3K9 | 1.54496207 |
| 21 | TGFBR2 | 1.51765503 |
| 22 | CAMK2D | 1.47383340 |
| 23 | ARAF | 1.45971088 |
| 24 | CAMK2B | 1.45455990 |
| 25 | TNIK | 1.45371502 |
| 26 | PKN1 | 1.39430398 |
| 27 | PAK6 | 1.37885876 |
| 28 | CASK | 1.36610459 |
| 29 | LATS1 | 1.35978471 |
| 30 | LIMK1 | 1.31915467 |
| 31 | SGK2 | 1.31442322 |
| 32 | PAK3 | 1.31016705 |
| 33 | EPHA2 | 1.30587059 |
| 34 | PDGFRA | 1.30281845 |
| 35 | PHKG1 | 1.27229810 |
| 36 | PHKG2 | 1.27229810 |
| 37 | SGK3 | 1.24417221 |
| 38 | STK38 | 1.23931236 |
| 39 | SGK494 | 1.22002892 |
| 40 | SGK223 | 1.22002892 |
| 41 | CDK19 | 1.21806710 |
| 42 | MAPK15 | 1.19489184 |
| 43 | MINK1 | 1.19332138 |
| 44 | ROCK2 | 1.16937673 |
| 45 | MAP3K13 | 1.15485532 |
| 46 | FER | 1.14875076 |
| 47 | MARK1 | 1.14484929 |
| 48 | CAMK2A | 1.13098762 |
| 49 | UHMK1 | 1.11684760 |
| 50 | CDK5 | 1.10477941 |
| 51 | FGFR3 | 1.09964168 |
| 52 | PNCK | 1.09192096 |
| 53 | GRK5 | 1.08111005 |
| 54 | DMPK | 1.05420639 |
| 55 | PRKCE | 1.05382570 |
| 56 | NEK6 | 1.04972850 |
| 57 | PTK2B | 1.04770219 |
| 58 | STK24 | 1.04181355 |
| 59 | JAK1 | 1.03448147 |
| 60 | TRPM7 | 1.01924891 |
| 61 | CAMK2G | 1.01700959 |
| 62 | STK38L | 1.00753891 |
| 63 | MAPK12 | 0.99774959 |
| 64 | ERBB3 | 0.96680689 |
| 65 | FGR | 0.92256138 |
| 66 | PIK3CA | 0.91426822 |
| 67 | DDR2 | 0.89468432 |
| 68 | SCYL2 | 0.89160323 |
| 69 | MUSK | 0.88987341 |
| 70 | CSNK1G2 | 0.88555325 |
| 71 | CSNK1A1L | 0.88430217 |
| 72 | PBK | 0.88245262 |
| 73 | PLK2 | 0.88187562 |
| 74 | MAP3K4 | 0.87526449 |
| 75 | PRKD1 | 0.87486397 |
| 76 | PRPF4B | 0.85169395 |
| 77 | MAPK7 | 0.85008273 |
| 78 | PIK3CG | 0.84625327 |
| 79 | PDPK1 | 0.84354497 |
| 80 | BMPR2 | 0.83585602 |
| 81 | CAMKK2 | 0.83328512 |
| 82 | MAP3K1 | 0.82256623 |
| 83 | OBSCN | 0.82202477 |
| 84 | DAPK2 | 0.80772487 |
| 85 | GRK7 | 0.80387646 |
| 86 | LMTK2 | 0.80005508 |
| 87 | MARK2 | 0.76471588 |
| 88 | CAMK1G | 0.76418926 |
| 89 | MAP3K7 | 0.74726432 |
| 90 | RET | 0.74335915 |
| 91 | NEK9 | 0.73456853 |
| 92 | CSNK1G3 | 0.73393672 |
| 93 | CDK14 | 0.72955090 |
| 94 | WNK3 | 0.71359884 |
| 95 | MST4 | 0.71090563 |
| 96 | PRKAA2 | 0.70307395 |
| 97 | PRKCH | 0.69497693 |
| 98 | BMPR1B | 0.69438959 |
| 99 | PRKCQ | 0.66767835 |
| 100 | PRKD3 | 0.65453147 |
| 101 | NTRK2 | 0.64450293 |
| 102 | MAP2K4 | 0.64004425 |
| 103 | NLK | 0.62107511 |
| 104 | MAP2K1 | 0.60491053 |
| 105 | PINK1 | 0.59071967 |
| 106 | MOS | 0.58857886 |
| 107 | FYN | 0.58145736 |
| 108 | EPHA3 | 0.58057908 |
| 109 | CAMKK1 | 0.57651859 |
| 110 | TTN | 0.57191643 |
| 111 | CSNK1G1 | 0.57182080 |
| 112 | PAK2 | 0.55551973 |
| 113 | MAP3K3 | 0.55061641 |
| 114 | KSR1 | 0.54781443 |
| 115 | CDK15 | 0.52546523 |
| 116 | PRKG1 | 0.51220129 |
| 117 | PDGFRB | 0.51028037 |
| 118 | SGK1 | 0.50615937 |
| 119 | CDK18 | 0.50600032 |
| 120 | FES | 0.50344224 |
| 121 | GRK1 | 0.49865576 |
| 122 | PDK1 | 0.49443375 |
| 123 | TIE1 | 0.48698114 |
| 124 | MYLK | 0.48260679 |
| 125 | MAP2K7 | 0.47961318 |
| 126 | MAPKAPK3 | 0.47890246 |
| 127 | FRK | 0.46752056 |
| 128 | PTK2 | 0.46049544 |
| 129 | FGFR1 | 0.45877768 |
| 130 | MAP3K12 | 0.45578284 |
| 131 | CAMK1 | 0.45535539 |
| 132 | MAPK10 | 0.45261451 |
| 133 | ROCK1 | 0.44573213 |
| 134 | PRKAA1 | 0.44369897 |
| 135 | NME1 | 0.44141294 |
| 136 | RPS6KA3 | 0.43427846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Circadian rhythm_Homo sapiens_hsa04710 | 2.06521761 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 1.88314716 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.84672989 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.81473422 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81061146 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.80462932 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71688670 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 1.68620542 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 1.66354455 |
| 10 | Salivary secretion_Homo sapiens_hsa04970 | 1.63475631 |
| 11 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63390954 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.60833389 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.58374524 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.54215775 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.54024928 |
| 16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50070230 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.49826491 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48253235 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.47022457 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.45989789 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.42159175 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.40943067 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.39756613 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33902066 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.29985623 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.29750210 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.29138145 |
| 28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.28822498 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.28799231 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.28677506 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.28444894 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27411852 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.27067798 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26623632 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.23554793 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22639832 |
| 37 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.20322310 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20140316 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.19077923 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16589700 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16274391 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13938919 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.13079110 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12937354 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08289994 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.05741833 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.05654024 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.05534206 |
| 49 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.03215067 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03031900 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.02136195 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.01267492 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00117177 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 0.99645709 |
| 55 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.98652218 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98589886 |
| 57 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.96656892 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.94768679 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93698854 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.92545884 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92344319 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.91863132 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91618013 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.89796499 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88092232 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87988827 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.87250028 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.86788844 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86696184 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86608442 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84461599 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84182904 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83641882 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83192221 |
| 75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82428675 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81554298 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80663707 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80455554 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.79968911 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77628544 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.77172437 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76853124 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.76755011 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76114669 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75764035 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75395491 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75151541 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74555793 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.73072933 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72773984 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72447580 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72111460 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.71088630 |
| 94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71036925 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70745832 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69444266 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69375636 |
| 98 | Protein export_Homo sapiens_hsa03060 | 0.69329279 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67844777 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66777812 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66466696 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64926032 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63357333 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62301945 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.61410299 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60636980 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60140686 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.59969575 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.59777210 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59373365 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59181293 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.58106401 |
| 113 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57688215 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56885557 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.55054193 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54941956 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54885461 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53716586 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.53334394 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53164609 |
| 121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51320868 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50828736 |
| 123 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49459258 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.48454363 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48352549 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47199775 |
| 127 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47157882 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44337694 |
| 129 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43458616 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41057122 |
| 131 | Platelet activation_Homo sapiens_hsa04611 | 0.40629952 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.38115023 |
| 133 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36867079 |
| 134 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36750408 |

